Titel: Antibody Production & Downstream Processing

Termin: 25.2.2004 bis 27.2.2004

Veranstaltungsort:
Sheraton San Diego Hotel & Marina
1380 Harbor Island Drive
San Diego, CA 92101
USA

Referenten: see their page for more information

Weitere Informationen:
http://www.lifesciencesinfo.com/antibodyprod

Kurzbeschreibung: With the recent FDA approvals of Humira™, Xolair® and Bexxar®, there are currently 15 recombinant antibodies in the market, and several more are in the advanced stages of clinical development. Some analysts predict that one drug alone, Genentech's Avastin™, could generate as much as $2 billion in revenue when approved for treatment of colon cancer.

IBC's 12th International Conference on Antibody Production and Downstream Processing, February 25-27, 2004, includes updates on all of the leading antibody-based therapeutics. With inside information from leading industry experts that can help you advance your antibody therapeutic program, this is the one event that scientists and executives consider a "must-attend."

Kontakt: Customer Service
IBC USA Conferences, Inc.
One Research Drive
Suite 400A
Westborough, MA 01581
USA

phone: +1 - 508 - 6 16 55 50
fax: +1 - 508 - 6 16 55 22

custserv@ibcusa.com

Veranstalter: ibc Life Sciences